Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Mechanism(s)Limiting Expiratory Airflow in Chronic, Stable Asthmatics Who Are Non-smokers

NCT01225913 is registered in ClinicalTrials.gov with Gelb, Arthur F., M.D. as lead sponsor.

NCT NCT01225913
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01225913 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Mechanism(s)Limiting Expiratory Airflow in Chronic, Stable Asthmatics Who Are Non-smokers
Lead sponsor
Gelb, Arthur F., M.D.
Phase
Phase 4
Overall status
Recruiting
Start date
October 31, 2007
Completion date
June 30, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma